How do I transition from active treatment to surveillance for Pancreatic Cancer

Transitioning from Active Treatment to Surveillance for Pancreatic Cancer

This is an important question, and it's great that you're thinking ahead about what comes next. Let me walk you through what this transition typically looks like and what you should discuss with your care team.

Understanding the Transition

What surveillance means: After completing your active treatment (chemotherapy, surgery, radiation, or a combination), surveillance is the ongoing monitoring to watch for any signs that cancer might return. It's not passive—it's structured follow-up care designed to catch any recurrence as early as possible.

According to Let's Win Pancreatic Cancer, the outcomes for pancreatic cancer patients diagnosed early through surveillance programs are dramatically different. When patients are caught at stage I disease, median survival reaches approximately 9.8 years, compared to the overall pancreatic cancer survival rate of about 11 percent. This underscores why careful monitoring after treatment completion is so valuable.

Key Components of Your Surveillance Plan

1. Imaging Schedule Your oncologist will establish a regular imaging schedule, typically including:

• CT scans (computed tomography) - usually every 3-6 months initially, then less frequently as time passes
• MRI or MRCP (magnetic resonance cholangiopancreatography) - may be used depending on your specific situation

The frequency typically decreases over time. For example, scans might be every 3 months for the first year, then every 6 months for years 2-3, then annually.

2. Blood Marker Monitoring

• CA 19-9 levels are tracked for pancreatic cancer. According to Let's Win Pancreatic Cancer, higher CA 19-9 numbers indicate active disease, so you want to see this number decrease or remain stable. Your doctor will establish your baseline and watch for any concerning increases.
• Regular blood work to monitor your overall health and organ function

3. Clinical Visits Regular appointments with your oncology team to:

• Review imaging and lab results
• Assess your physical symptoms and side effects from treatment
• Discuss any new concerns

Important Questions to Ask Your Healthcare Team

As you transition to surveillance, Let's Win Pancreatic Cancer recommends asking your doctor these specific questions:

1. "What is my specific surveillance schedule?" - Get the exact timeline for scans and blood work for at least the first 2 years.

2. "What symptoms should I report immediately between appointments?" - Know the warning signs that warrant urgent contact (unexplained weight loss, jaundice, severe abdominal pain, etc.).

3. "How will we monitor my CA 19-9 levels, and what changes would be concerning?" - Understand what numbers mean and what trends matter.

4. "Do I need genetic testing or molecular profiling of my tumor if I haven't had it?" - According to Let's Win Pancreatic Cancer, genetic testing is now recommended in national guidelines. This information can be valuable if recurrence occurs, as it may identify targeted therapy options.

5. "What support services are available for managing long-term side effects?" - Many patients experience lasting effects from treatment (digestive issues, fatigue, neuropathy).

6. "Should I participate in any clinical trials during surveillance?" - New treatments are constantly being studied, and you may be eligible for trials that could benefit you.

Managing Long-Term Side Effects During Surveillance

Let's Win Pancreatic Cancer emphasizes that surveillance isn't just about watching for cancer—it's also about managing your quality of life:

• Pancreatic enzyme replacement: If part of your pancreas was removed or the tumor affected enzyme flow, you may need ongoing enzyme supplements to help with digestion
• Exercise: Research shows regular physical activity during and after treatment can help counteract fatigue, improve sleep, and reduce anxiety
• Nutrition: Work with a dietitian to address any ongoing digestive or nutritional challenges
• Emotional support: Consider counseling or support groups—the emotional weight of surveillance can be significant

The Role of Molecular Profiling Going Forward

According to Dr. [removed] Strickler (Duke University, in the Cancer Patient Lab webinar "Navigating Pancreatic Cancer"), every pancreatic cancer patient should ask their doctor: "Have you done the molecular profiling on my cancer? Can I see the report?"

This is important because:

• If your cancer recurs, knowing its genetic profile (KRAS mutations, BRCA status, MSI status, etc.) helps your doctor choose the most effective targeted therapy
• You should keep a printed copy of this report—it often doesn't transfer between medical systems when you seek second opinions
• National guidelines now recommend genetic testing for inherited mutations, which can affect your treatment options if needed

What to Expect Emotionally

Transitioning from the structure of active treatment to surveillance can feel strange. You're no longer in "fight mode," but you're also not in "all clear" mode. This is normal. Many patients report:

• Relief that active treatment is over
• Anxiety about scans and results
• Uncertainty about what "normal" looks like

These feelings are valid, and your care team should have resources to help.

Key Takeaway

Let's Win Pancreatic Cancer emphasizes that surveillance works—when patients stay engaged with their monitoring program, outcomes improve significantly. The key is maintaining consistent follow-up, staying informed about your tumor's molecular profile, and communicating openly with your healthcare team about any changes or concerns.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.